Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
SANB was delisted on the 19th of October, 2022.
41 hedge funds and large institutions have $114M invested in Sanaby Health Acquisition Corp. I Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$11.8M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$8.62M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$6.24M |
| 4 |
D.E. Shaw & Co
New York
|
+$5.63M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$4.96M |
Top Sellers
SANB Hedge Fund Activity: Q4 2021 in Review
41 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) for Q4 2021, worth a combined $114M.
Buyers outnumbered sellers: 41 funds opened new SANB positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $11.8M.
- 41 institutional investors held Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $114M of Sanaby Health Acquisition Corp. I Class A Common Stock stock for Q4 2021.
- 41 funds opened new Sanaby Health Acquisition Corp. I Class A Common Stock positions in Q4 2021 and 0 closed out, a net change of +41 holders.
- The largest Sanaby Health Acquisition Corp. I Class A Common Stock buyer in Q4 2021 was Saba Capital Management, an estimated $11.8M added.
Based on aggregated 13F filings for Q4 2021.